Find the latest pharmaceutical market place for formulations enquiry about Buprenorphine Hydrochloride on PharmaCompass.com.

Tender// Various Finished Dosage Formulations needed in Moldova [ENA11116]

Center for Centralized Public Procurement in Health is looking for supplies of Various Finished Dosage Formulations for commercial purpose. The deadline is 20-Sep-2021.
1. Zidovudine (10 mg/ ml) Drinkable Solution. The required quantity is 41,760 units.
2. Ceftriaxone (1000 mg) Powder / Solution for Injection. The required quantity is 2,320 units.
3. Buprenorphine Hydrochloride (8 mg) Sublingual Tablets. The required quantity is 19,000 units.
4. Emtricitabine (200 mg) + Tenofovir Disoproxil (245 mg) or Emtricitabine (200 mg) + Tenofovir Disoproxil Fumarate (300 mg) Tablets. The required quantity is 57,509 units.
5. Trimethoprim (400 mg) + Sulfamethoxazole (80 mg) Tablets. The required quantity is 409,310 units.
6. Nevirapine (10 mg/ ml) Drinkable Suspension. The required quantity is 22,400 units.
7. Naloxone Hydrochloride (0.4 mg / ml) Injectable Solution. The required quantity is 4,068 units.

Reply

13 Aug 2021

india-flag Flag

Various Finished Dosage Formulations needed in India [ENA09610]

A fully integrated pharmaceutical company with services extended from delivering pharmaceutical products to pharma mergers is looking for suppliers of Various Finished Dosage Formulations for clinical trial purposes as RLD.
1. Nubain [Nalbuphine Hydrochloride (10 mg/ ml) Solution]. The required quantity is 60 units.
2. Omega [Naloxone (0.4 mg/ ml in 1 ml and 1 mg/ ml in 2 ml) Vial]. The required quantity is 80 units and 50 units respectively.
3. Sandoz [Naloxone (0.4 mg/ ml in 1 ml) Ampoule]. The required quantity is 80 units.
4. Suboxone (8/ 2 mg and 2/ 0.5 mg) Tablets. The required quantity is 200 units for each.
5. Jansacn [Fentanyl (50 mcg/ ml in 2 ml and 5 ml) Injection]. The required quantity is 80 units and 50 units respectively.
6. Metadol [Methadone (1 mg, 5 mg, 10 mg and 25 mg) Tablets]. The required quantity is 200 units for each.

Reply

30 Jan 2021

Various dossiers required for out-licensing in Iran [ENA03557]

A leading and growing pharmaceutical company is looking for the following dossiers for technology transfer for the Iranian market:
1) Buprenorphine HCl USP 150mg extended-release tablets
2) Morphine Sulfate extended-release 30mg tablets
3) Methadone extended-release tablets
4) Alprazolam extended-release tablets

Reply

02 Mar 2019

Enquiry// Suboxone (Buprenorphine+ Naloxone) formulations needed in Saudi Arabia/UAE [ENA00963]

Alpha Pharma, a distribution company operating in the Gulf region is looking for suppliers of Suboxone (Buprenorphine+ Naloxone) formulations for supply to hospitals and pharmacies. Interested suppliers should contact Nouf via Email: noufalhaqbani@gmail.com or Tel: 00966534426426.

Reply

02 Jun 2018

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.